Dendritic cells (DC) play an important role in the development and maintenance of immune tolerance. Although the inhibitory receptor ILT4/LILRB2 has been related with the tolerogenic phenotype of DC, the possible role of this receptor in the breakdown of DC tolerogenic function in systemic lupus erythematosus (SLE) has not been elucidated. In this study, we analyzed the expression and function of the inhibitory receptor ILT4 in DC from SLE patients. We found that the percentage of ILT4 positive plasmacytoid DC and myeloid DC is significantly diminished in SLE patients. Interestingly, ligation of ILT4 did not affect the maturation or immunogenic capability of DC in healthy controls. In contrast, in SLE patients we observed an inhibitory effect of ILT4 on the immunogenic capability of DC. ILT4 was shown not to have a crucial role in regulating the maturation and function of DC from healthy controls but is partially involved in the maturation process and immunogenic capability of DC from SLE patients, suggesting that other inhibitory receptors, involved in the regulation of DC tolerogenic function, may be impaired in this autoimmune disease.
Background Natural killer (NK) cells are large granular lymphocytes that belong to the innate immunity. The activation or inhibition of NK cells is regulated by several membrane receptors, commonly designated as NK cell receptors (NKR). Despite its well-known functions it has been recently reported that NK cells are also involved in the regulation of the adaptive immune response. The NK regulatory mechanisms include the acquisition of MHC class II and costimulatory molecules to sub-optimal levels in order to induce T cell anergy. Moreover, it has been found that NK cells are able to inhibit T cell proliferation by lysing dendritic cells (DC). Systemic lupus erythematosus (SLE) is an autoimmune disease, which results from numerous immunological abnormalities. It has been described that SLE patients display impairment in both, the levels and the cytotoxic function of NK cells. However, NK cells regulatory function in SLE has not been evaluated. Objectives We aim to study the NKR and costimulatory molecules expression in NK cells from SLE patients, as well as its inhibitory function. Methods Fifteen SLE patients according to the classification criteria of the American College of Rheumatology and seven healthy controls have been included. The expression of NKG2D, NKG2C, NKG2A, NKp46, NKp30, ILT2, CD161, and costimulatory molecules: CD80, CD86, HLA-DR, CD134 (OX40), was evaluated in peripheral blood NK cells (CD3-CD56+) by multiparametric flow cytometry. In order to evaluate the inhibitory function of NK cells, we performed co-cultures with NK cells and autologous, CFSE loaded, immature DC or mature DC as targets cells; co-cultures were done at different NK cells–DC ratios (0:1, 1:5, 5:1, 1:0) for 24h and 48 h; the percentage of DC lysis was assessed by flow cytometry. Results We found that SLE patients show a similar pattern of NKR expression than healthy controls. However, the inhibitory receptor ILT2 and the activator NKR, NKp30 and NKG2C, showed a slight increase in their expression. Furthermore, we observed that the expression of the costimulatory molecules CD80, CD86 and CD134, as well as HLA-DR was increased in SLE patients compared to healthy controls. In addition, we found that NK from SLE patients are less capable to lyse immature DC compared with control NK cells. In contrast, NK cells from SLE patients are more efficient lysing mature DC compared with controls. Conclusions Our results suggest that NK cells from SLE patients show an activating phenotype, which, in addition to the high expression of HLA-DR and costimulatory molecules provides them with the ability to present antigens and activate T cells. Furthermore, NK cells from SLE patients do not lyse immature DC efficiently, which may promote the presentation of auto-antigens by DC resulting in the activation of autoreactive T cells. All the above may contribute to SLE pathogenesis. References Novel APC-like properties of human NK cells directly regulate T cell activation. Hanna J, et al. J Clin Invest 2004; 114:1612-1623. Natural killer (...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.